Matthew D. Hellmann

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Matthew D. Hellmann

Jul 26, 2024, 00:16 | Insight

Impact of the intratumoral microbiome of NSCLC on outcomes with immunotherapy

Stephen Liu shared on X: "Impressive work on impact of the intratumoral microbiome of NSCLC…

Jul 25, 2024, 00:32 | Blog

Jarushka Naidoo: Can intratumor eschericia improve OS from ICIs in NSCLC

Jarushka Naidoo shared a post on X: ''Can intratumor eschericia (E) bring immune cells to…

Jul 15, 2024, 11:11 | Blog

Enrico Lugli: Our commentary on fantastic triads paper

Enrico Lugli shared a post on X: ''Our commentary 'Immune cell triads reprogram exhausted CD8+ T…

Jun 26, 2024, 02:10 | Insight

Intratumoral immune triads are required for effective immunotherapy

NCI Division of Cancer Biology shared on X: "Using preclinical models in an NCI-funded study,…

All: 4 Posts: 1 - 100

'

Who From Oncology is Featured in TIME100 Health 2025?

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023